The therapy of Cushing’s disease in adults and children: an update
The DOI matches its Crossref record.
Abstract
Cushing's disease (CD) is a rare endocrine disorder resulting from excessive production of adrenocorticotrophin hormone by a pituitary adenoma. The consequent hypercortisolaemia gives rise to characteristic features of the disease and its morbidities. Treatments aim to restore normal cortisol levels, provide long-term control of the disease and the tumour, and the improvement of patient well-being. The first line of treatment remains transsphenoidal surgery with remission rates of 65-90% in CD secondary to a pituitary microadenoma. Second-line treatment includes repeat surgery, radiotherapy, medical therapy, and bilateral adrenalectomy. The success rate of radiotherapy ranges from 46% to 74% and is probably independent of the mode of delivery of the radiation, but may take several years to become effective. Medical therapy is useful in acutely unwell patients or while awaiting radiotherapy to become effective. The most often-used medical agents include metyrapone and ketoconazole, which inhibit steroidogenesis; less often, centrally-acting drugs or a glucocorticoid receptor blocker are used, but experience with them is more limited. Bilateral adrenalectomy remains an important treatment option to control unresponsive severe hypercortisolism, particularly in patients with severe CD.The management of childhood CD does not differ from adult disease, with transsphenoidal surgery as successful as in adults but radiotherapy is more rapid in onset. Regardless of the age of the patient, Cushing's disease remains a challenge to the physician and requires a multidisciplinary approach to achieve the most desirable outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metyrapone blocks the 11β-hydroxylase enzyme, required for the last step of cortisol synthesis from 11-deoxycortisol. Consequently, as shown in Figure 1, steroid precursors are channeled through the androgen pathways resulting in increased secretion of adrenal androgens.”
From ACTH Antagonists (2016) · cites this paper as [24]
Citations
Cites
Still being checked.
Cited by
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Giraldi, F. P., Cavallo, L. M., Tortora, F., Pivonello, R., Colao, A., Cappabianca, P., & Mantero, F. (2015) · Neurosurgical Focus · doi:10.3171/2014.11.focus14766 · Cited by 107
An update on Cushing syndrome in pediatrics
Stratakis, C. A. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.010 · Cited by 54
Clark, A. J., Forfar, R., Hussain, M., Jerman, J., McIver, E., Taylor, D., & Chan, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00101 · Cited by 49
“The consensus from most researchers seems to be that ACTH [11–24] is not an effective ACTH antagonist.”
BackgroundInfluentialYamada, S., Inoshita, N., Fukuhara, N., Yamaguchi‐Okada, M., Nishioka, H., Takeshita, A., Suzuki, H., Itô, J., & Takeuchi, Y. (2015) · Endocrine Journal · doi:10.1507/endocrj.15-0463 · Cited by 39
Metadata
- Authors
- Juszczak, A., Ertorer, M., & Grossman, A.
- Affiliations
- Churchill Hospital (GB)
- Faculty of Medicine, Adana Teaching and Research Centre - Endocrinology and Metabolism, Baskent University, Adana, Turkey
- Corresponding author
- Juszczak, A.
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 2012-12-07
- Volume
- 45
- Issue
- 02
- Pages
- 109-117
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W1975407232
- Cited by
- 28
- References
- 0
- Citations by year
- 2024: 1 · 2023: 4 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 12 · 2014: 1
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's disease, pituitary adenoma, transsphenoidal surgery, pituitary radiotherapy, medical therapy, metyrapone, ketoconazole, bilateral adrenalectomy, hypercortisolism, pediatric Cushing's disease, steroidogenesis inhibition
- MeSH terms
- Adenoma, Adrenalectomy, Adult, Child, Combined Modality Therapy, Decision Trees, Enzyme Inhibitors, Hormone Antagonists, Humans, Radiosurgery, Adrenergic Antagonists, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The therapy of Cushing’s disease in adults and children: an update. https://app.cochat.ai/papers/10.1055/s-0032-1330009
- The paper
- Juszczak, A., Ertorer, M., & Grossman, A. (2012). The therapy of Cushing’s disease in adults and children: an update. Hormone and Metabolic Research. https://doi.org/10.1055/s-0032-1330009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.